These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 36938543)

  • 1. Seneca Valley virus replicons are packaged in
    Bryant JD; Lee JS; De Almeida A; Jacques J; Chang CH; Fassler W; Quéva C; Lerner L; Kennedy EM
    Mol Ther Oncolytics; 2023 Mar; 28():321-333. PubMed ID: 36938543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seneca Valley Virus Suppresses Host Type I Interferon Production by Targeting Adaptor Proteins MAVS, TRIF, and TANK for Cleavage.
    Qian S; Fan W; Liu T; Wu M; Zhang H; Cui X; Zhou Y; Hu J; Wei S; Chen H; Li X; Qian P
    J Virol; 2017 Aug; 91(16):. PubMed ID: 28566380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Structure-Guided Genetic Modification Strategy: Developing Seneca Valley Virus Therapy against Nonsensitive Nonsmall Cell Lung Carcinoma.
    Zhao Z; Cao L; Sun Z; Liu W; Li X; Fang K; Shang X; Hu J; Chen H; Lou Z; Qian P
    J Virol; 2023 May; 97(5):e0045923. PubMed ID: 37097154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seneca Valley Virus 3C
    Xue Q; Liu H; Zhu Z; Xue Z; Liu X; Zheng H
    Pathogens; 2020 Jun; 9(6):. PubMed ID: 32512928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncolytic Seneca Valley Virus: past perspectives and future directions.
    Burke MJ
    Oncolytic Virother; 2016; 5():81-9. PubMed ID: 27660749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RIG-I is responsible for activation of type I interferon pathway in Seneca Valley virus-infected porcine cells to suppress viral replication.
    Li P; Zhang X; Cao W; Yang F; Du X; Shi Z; Zhang M; Liu X; Zhu Z; Zheng H
    Virol J; 2018 Oct; 15(1):162. PubMed ID: 30352599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolving role of seneca valley virus and its biomarker TEM8/ANTXR1 in cancer therapeutics.
    Corbett V; Hallenbeck P; Rychahou P; Chauhan A
    Front Mol Biosci; 2022; 9():930207. PubMed ID: 36090051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective autophagy receptor SQSTM1/ p62 inhibits Seneca Valley virus replication by targeting viral VP1 and VP3.
    Wen W; Li X; Yin M; Wang H; Qin L; Li H; Liu W; Zhao Z; Zhao Q; Chen H; Hu J; Qian P
    Autophagy; 2021 Nov; 17(11):3763-3775. PubMed ID: 33719859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of intravenously administered synthetic RNA virus immunotherapy for the treatment of cancer.
    Kennedy EM; Denslow A; Hewett J; Kong L; De Almeida A; Bryant JD; Lee JS; Jacques J; Feau S; Hayes M; McMichael EL; Wambua D; Farkaly T; Rahmeh AA; Herschelman L; Douglas D; Spinale J; Adhikari S; Deterling J; Scott M; Haines BB; Finer MH; Ashburn TT; Quéva C; Lerner L
    Nat Commun; 2022 Oct; 13(1):5907. PubMed ID: 36207308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seneca Valley Virus Induces DHX30 Cleavage to Antagonize Its Antiviral Effects.
    Wen W; Zheng Z; Wang H; Zhao Q; Yin M; Chen H; Li X; Qian P
    J Virol; 2022 Sep; 96(17):e0112122. PubMed ID: 36000840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergetic Contributions of Viral VP1, VP3, and 3C to Activation of the AKT-AMPK-MAPK-MTOR Signaling Pathway for Seneca Valley Virus-Induced Autophagy.
    Song J; Hou L; Quan R; Wang D; Jiang H; Liu J
    J Virol; 2022 Jan; 96(2):e0155021. PubMed ID: 34757844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seneca Valley Virus 3C
    Song J; Quan R; Wang D; Liu J
    Microbiol Spectr; 2022 Apr; 10(2):e0030422. PubMed ID: 35357201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seneca Valley virus 3C
    Song J; Wang D; Quan R; Liu J
    Virulence; 2021 Dec; 12(1):3125-3136. PubMed ID: 34923914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunomodulatory Arming Factors-The Current Paradigm for Oncolytic Vectors Relies on Immune Stimulating Molecules.
    Peters CWD; Nigim F
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seneca Valley Virus Enters PK-15 Cells via Caveolae-Mediated Endocytosis and Macropinocytosis Dependent on Low-pH, Dynamin, Rab5, and Rab7.
    Hou L; Tong X; Pan Y; Shi R; Liu C; Guo J; Shi Y; Yang X; Wang Y; Feng X; Zhou J; Liu J
    J Virol; 2022 Dec; 96(24):e0144622. PubMed ID: 36472440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seneca Valley Virus 2C and 3C
    Liu T; Li X; Wu M; Qin L; Chen H; Qian P
    Front Microbiol; 2019; 10():1202. PubMed ID: 31191506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mfn2 is responsible for inhibition of the RIG-I/IRF7 pathway and activation of NLRP3 inflammasome in Seneca Valley virus-infected PK-15 cells to promote viral replication.
    Deng H; Zhu S; Zhu L; Sun J; Ding Y; Li F; Jian Z; Zhao J; Deng L; Deng J; Deng Y; Guo H; Sun X; Lai SY; Tang H; Cui H; Ge LP; Xu Z
    Front Immunol; 2022; 13():955671. PubMed ID: 35958608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engineering Oncolytic Coxsackievirus A21 with Small Transgenes and Enabling Cell-Mediated Virus Delivery by Integrating Viral cDNA into the Genome.
    Sam M; Selman M; Zhao W; Jung J; Willingham A; Phan U; Starling GC; Gao Q
    J Virol; 2023 May; 97(5):e0030923. PubMed ID: 37070982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intercellular transmission of Seneca Valley virus mediated by exosomes.
    Xu G; Xu S; Shi X; Shen C; Hao J; Yan M; Zhang D; Zhu Z; Zhang K; Zheng H; Liu X
    Vet Res; 2020 Jul; 51(1):91. PubMed ID: 32678013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seneca Valley Virus 3C
    Song J; Quan R; Wang D; Liu J
    Front Microbiol; 2022; 13():945443. PubMed ID: 35875542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.